378 related articles for article (PubMed ID: 16699011)
1. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.
Koutsoudakis G; Kaul A; Steinmann E; Kallis S; Lohmann V; Pietschmann T; Bartenschlager R
J Virol; 2006 Jun; 80(11):5308-20. PubMed ID: 16699011
[TBL] [Abstract][Full Text] [Related]
2. Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production.
Kamada K; Shoji I; Deng L; Aoki C; Ratnoglik SL; Wakita T; Hotta H
Microbes Infect; 2012 Jan; 14(1):69-78. PubMed ID: 21917232
[TBL] [Abstract][Full Text] [Related]
3. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
[TBL] [Abstract][Full Text] [Related]
4. Novel chimeric genotype 1b/2a hepatitis C virus suitable for high-throughput screening.
Zhang Y; Weady P; Duggal R; Hao W
Antimicrob Agents Chemother; 2008 Feb; 52(2):666-74. PubMed ID: 18039917
[TBL] [Abstract][Full Text] [Related]
5. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
6. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.
Liu S; Xiao L; Nelson C; Hagedorn CH
PLoS One; 2012; 7(9):e44965. PubMed ID: 23028707
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.
Pietschmann T; Kaul A; Koutsoudakis G; Shavinskaya A; Kallis S; Steinmann E; Abid K; Negro F; Dreux M; Cosset FL; Bartenschlager R
Proc Natl Acad Sci U S A; 2006 May; 103(19):7408-13. PubMed ID: 16651538
[TBL] [Abstract][Full Text] [Related]
9. Bile acids specifically increase hepatitis C virus RNA-replication.
Chhatwal P; Bankwitz D; Gentzsch J; Frentzen A; Schult P; Lohmann V; Pietschmann T
PLoS One; 2012; 7(4):e36029. PubMed ID: 22558311
[TBL] [Abstract][Full Text] [Related]
10. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.
Gottwein JM; Jensen TB; Mathiesen CK; Meuleman P; Serre SB; Lademann JB; Ghanem L; Scheel TK; Leroux-Roels G; Bukh J
J Virol; 2011 Sep; 85(17):8913-28. PubMed ID: 21697486
[TBL] [Abstract][Full Text] [Related]
11. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.
Mateu G; Donis RO; Wakita T; Bukh J; Grakoui A
Virology; 2008 Jul; 376(2):397-407. PubMed ID: 18455749
[TBL] [Abstract][Full Text] [Related]
12. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
[TBL] [Abstract][Full Text] [Related]
13. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
14. Direct visualization of hepatitis C virus-infected Huh7.5 cells with a high titre of infectious chimeric JFH1-EGFP reporter virus in three-dimensional Matrigel cell cultures.
Liu S; Chen R; Hagedorn CH
J Gen Virol; 2014 Feb; 95(Pt 2):423-433. PubMed ID: 24243732
[TBL] [Abstract][Full Text] [Related]
15. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
16. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles.
Steinmann E; Brohm C; Kallis S; Bartenschlager R; Pietschmann T
J Virol; 2008 Jul; 82(14):7034-46. PubMed ID: 18480457
[TBL] [Abstract][Full Text] [Related]
17. Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
Shirasago Y; Fukazawa H; Aizaki H; Suzuki T; Suzuki T; Sugiyama K; Wakita T; Hanada K; Abe R; Fukasawa M
J Gen Virol; 2018 Oct; 99(10):1407-1417. PubMed ID: 30045785
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
Li Y; Yamane D; Lemon SM
J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
[TBL] [Abstract][Full Text] [Related]
19. Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation.
Koutsoudakis G; Perez-del-Pulgar S; Coto-Llerena M; Gonzalez P; Dragun J; Mensa L; Crespo G; Navasa M; Forns X
PLoS One; 2011; 6(8):e23587. PubMed ID: 21887279
[TBL] [Abstract][Full Text] [Related]
20. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
